**Question:** A child on b2 agonists for treatment of bronchial asthma may exhibit all of the following features except:

A. Increased heart rate
B. Increased respiratory rate
C. Hypotension
D. Hypoventilation

**Core Concept:**

B2 agonists, also known as beta-2 agonists or beta-2 stimulants, are a class of medications used to treat asthma and other respiratory conditions by relaxing bronchial smooth muscles, widening the airways, and improving airflow. The primary effect of B2 agonists is to stimulate beta-2 receptors, leading to adenyl cyclase activation, increased cyclic AMP production, and subsequent relaxation of bronchial smooth muscles.

**Why the Correct Answer is Right:**

Correct answer D (hypoventilation) is not a typical feature of b2 agonist therapy. B2 agonists primarily act on beta-2 receptors of the respiratory system, resulting in bronchodilation, improved airflow, and reduced airway resistance. These medications do not directly affect the cardiovascular system or cause hypoventilation in healthy individuals.

**Why Each Wrong Option is Incorrect:**

A. Increased heart rate (hypertension) is a potential side effect of b2 agonist therapy, particularly in uncontrolled asthma or when using high doses. However, this is not the primary effect of these medications, so it is not the reason a child on b2 agonist therapy would not exhibit hypoventilation.

B. Increased respiratory rate (tachypnea) is a common side effect of b2 agonist therapy, particularly in acute asthma exacerbations when the child is struggling to breathe. This is an indirect result of the primary effect on airway smooth muscles and does not imply hypoventilation or decreased ventilation.

C. Hypotension (decreased blood pressure) is a rare adverse effect of b2 agonist therapy, particularly when used in high doses or in patients with cardiovascular disease. It is not the primary effect of these medications, so it is not the reason a child on b2 agonist therapy would not exhibit hypoventilation.

**Clinical Pearl:**

In children with asthma, b2 agonists are a crucial component of asthma management as they help to relieve bronchoconstriction and improve respiratory function. When using these medications, clinicians should monitor for potential side effects such as hypertension (increased heart rate) and tachypnea (increased respiratory rate), but hypoventilation (decreased ventilation) is not a typical side effect or reason the child would not exhibit the primary effect of bronchodilation.

**Correct Answer:** D (hypoventilation) is not the correct answer because it contradicts the primary effect of b2 agonist therapy, which is bronchodilation and improved ventilation. The correct answer should explain the mechanism of action and side effects of b2 agonists, rather than focusing on hypoventilation as the reason for the primary bronchodilator effect.